科源制药 (301281.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

现金流量表(科源制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市前上市前上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 82,272,798.86355,921,587.93263,199,723.21185,643,757.0298,176,865.57342,323,589.77146,143,201.2271,612,001.07
 收到的税费返还(元) 1,664,694.7114,957,894.8814,214,106.501,944,954.94913,001.932,385,063.772,385,063.771,505,815.64
 收到其他与经营活动有关的现金(元) 4,382,678.1514,825,395.229,893,725.903,248,775.261,148,451.147,833,839.605,050,268.233,516,475.65
 经营活动现金流入小计(元) 88,320,171.72385,704,878.03287,307,555.61190,837,487.22100,238,318.64352,542,493.14153,578,533.2276,634,292.36
 购买商品、接受劳务支付的现金(元) 34,438,857.46134,481,935.31117,644,167.4575,566,318.6640,942,941.4096,210,316.1251,544,880.1333,708,727.87
 支付给职工以及为职工支付的现金(元) 25,784,164.8089,178,740.3464,630,121.2842,428,321.9720,147,835.0174,456,622.8238,683,453.4117,914,931.67
 支付的各项税费(元) 10,730,086.5940,145,086.3730,432,502.0021,150,299.1614,388,782.1227,177,719.975,619,004.531,550,143.70
 支付其他与经营活动有关的现金(元) 19,007,946.0184,868,126.1955,762,781.4330,540,365.3710,605,501.4638,839,098.9016,724,217.9010,435,216.19
 经营活动现金流出的平衡项目(元) ------0.01-
 经营活动现金流出小计(元) 89,961,054.86348,673,888.21268,469,572.16169,685,305.1686,085,059.99236,683,757.81112,571,555.9863,609,019.43
 经营活动产生的现金流量净额(元) -37,030,989.82-21,152,182.06-115,858,735.3341,006,977.24-
二、投资活动产生的现金流量
 收回投资收到的现金(元) 3,526,111,048.66652,806,471.59------
 取得投资收益收到的现金(元) 1,591,522.916,298,036.88130,994,391.63-----
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) -195,778.00165,778.0095,830.00-399,845.86--
 收到其他与投资活动有关的现金(元) 202,646.77-------
 投资活动现金流入小计(元) 3,527,905,218.34659,300,286.47131,160,169.6395,830.00-399,845.86--
 购建固定资产、无形资产和其他长期资产支付的现金(元) 86,645,979.3070,148,453.1935,380,085.3720,100,429.3113,409,829.6831,106,843.2720,233,705.867,746,230.49
 投资支付的现金(元) 3,231,843,016.671,191,278,454.92677,500,000.00597,500,000.00----
 投资活动现金流出小计(元) 3,318,488,995.971,261,426,908.11712,880,085.37617,600,429.3113,409,829.6831,106,843.2720,233,705.867,746,230.49
 投资活动产生的现金流量净额(元) 209,416,222.37-602,126,621.64-581,719,915.74-617,504,599.31-13,409,829.68-30,706,997.41-20,233,705.86-7,746,230.49
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) 1,000,000.00782,943,530.00782,943,530.00782,943,530.00782,943,530.00---
 收到其他与筹资活动有关的现金(元) ----422,952.86---
 筹资活动现金流入小计(元) 1,000,000.00782,943,530.00782,943,530.00782,943,530.00783,366,482.86---
 分配股利、利润或偿付利息支付的现金(元) -30,940,000.0030,561,288.3430,561,288.34----
 支付其他与筹资活动有关的现金(元) -12,195,562.8010,656,603.8010,656,603.80610,965.731,806,000.00956,000.00289,018.87
 筹资活动现金流出小计(元) -43,135,562.8041,217,892.1441,217,892.14610,965.731,806,000.00956,000.00289,018.87
 筹资活动产生的现金流量净额(元) 1,000,000.00739,807,967.20741,725,637.86741,725,637.86782,755,517.13-1,806,000.00-956,000.00-289,018.87
四、汇率变动对现金及现金等价物的影响(元) 261,598.54522,555.42103,292.621,225,552.29-75,400.79279,628.0830,436.27-7,154.14
五、现金及现金等价物净增加额(元) 209,036,937.77175,234,890.80178,946,998.19146,598,772.90783,423,545.3183,625,366.0019,847,707.654,982,869.43
 加:期初现金及现金等价物余额(元) 359,510,517.11148,974,223.74148,974,223.74148,974,223.74148,974,223.7465,348,857.7465,348,857.7465,348,857.74
 期末现金及现金等价物余额(元) 568,547,454.88324,209,114.54327,921,221.93295,572,996.64932,397,769.05148,974,223.7485,196,565.3970,331,727.17
补充资料:
 净利润(元) -77,039,439.15-51,204,444.88-91,278,406.7851,065,919.18-
 资产减值准备(元) -3,492,184.66--791,449.88-3,552,418.21768,201.31-
 固定资产和投资性房地产折旧(元) -45,888,958.97-16,964,294.16-30,602,882.6113,761,325.55-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) -45,888,958.97-16,964,294.16-30,602,882.6113,761,325.55-
 无形资产摊销(元) -3,058,868.39-1,529,434.18-3,031,076.221,511,988.96-
 长期待摊费用摊销(元) -1,637,781.71--1,355,485.96-1,691,791.56816,543.82-
 处置固定资产、无形资产和其他长期资产的损失(元) --345,993.55--74,662.69--365,237.3411,754.34-
 固定资产报废损失(元) -301,189.23-71,167.37----
 公允价值变动损失(元) --543,183.10------
 财务费用(元) --522,555.42--1,225,552.29--279,628.08-30,436.27-
 投资损失(元) --12,201,059.45------
 递延所得税(元) -1,175,478.37--594,781.88-7,020,905.901,724,252.22-
  其中:递延所得税资产减少(元) --918,473.07-35,511.55--475,582.81-395,862.02-
 递延所得税负债增加(元) -2,093,951.44--630,293.43-7,496,488.712,120,114.24-
 存货的减少(元) --42,792,474.45--20,269,328.96-16,066,030.75-8,688,399.40-
 经营性应收项目的减少(元) --18,879,521.75--17,396,948.21--43,019,565.78-40,171,851.16-
 经营性应付项目的增加(元) --20,278,122.94--6,908,948.66-6,279,654.5018,362,954.77-
 现金的期末余额(元) -324,209,114.54-295,572,996.64-148,974,223.7485,196,565.39-
 减:现金的期初余额(元) -148,974,223.74-148,974,223.74-65,348,857.7465,348,857.74-
 现金及现金等价物的净增加额(元) -175,234,890.80-146,598,772.90-83,625,366.0019,847,707.65-
公告日期 2024-04-222024-03-292023-10-262023-08-222023-04-262023-03-172022-09-282023-04-26
审计意见(境内) 标准无保留意见标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院